A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)
Status:
Completed
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
The primary objective of this trial was to determine the effective doses and treatment period
of PDC-1421 Capsule in subjects with ADHD.
The secondary objective was to evaluate the safety of PDC-1421 Capsule in subjects receiving
PDC-1421 at various dose levels.